J. Buendía

发表

Social and economic variables related with Paraquat self-poisoning: an ecological study

Andres F Zuluaga, J. Buendía, G. R. Restrepo Chavarriaga, 2020, BMC Public Health.

TLR4 Gene Polymorphisms Interaction With Ascaris Infection in Severe RSV Bronchiolitis

F. Polack, J. Buendía, Erika Fernanda Lindarte, 2022, Frontiers in Pediatrics.

Disability-adjusted life years for acute bronchiolitis in infants in Colombia

J. Buendía, Diana Guerrero Patiño, D. Patiño, 2021, The Pan African medical journal.

Disability-adjusted life years for respiratory syncytial virus in children under 2 years

F. Polack, J. Buendía, Juana Patricia Sánchez Villamil, 2020, BMC Public Health.

Cost Utility of Intermittent Inhaled Corticosteroids in Preschoolers with Viral-Triggered Wheeze.

J. Buendía, Diana Guerrero Patiño, Juan Esteban Giraldo Ramírez, 2022, Pediatric allergy, immunology, and pulmonology.

Cost-utility of azithromycin in patients with severe asthma

J. Buendía, J. E. Feliciano-Alfonso, Diana Guerrero Patiño, 2021, The Journal of asthma : official journal of the Association for the Care of Asthma.

Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma

J. Buendía, Diana Guerrero Patiño, D. Patiño, 2021, BMC Pulmonary Medicine.

Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma

J. Buendía, Diana Guerrero Patiño, D. Patiño, 2021, BMC Pulmonary Medicine.

Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma.

J. Buendía, Diana Guerrero Patiño, H. Talamoni, 2021, Pediatric pulmonology.

Risk factors associated with pulmonary exacerbations in pediatric patients with cystic fibrosis.

A. Teper, L. Galanternik, S. Lubovich, 2019, Archivos argentinos de pediatria.

Disability-adjusted Life Years for respiratory syncytial virus in children under 2 years

F. Polack, J. Buendía, Juana Patricia Sánchez Villamil, 2020 .

Cost of illness of RSV infection in a middle-income tropical country.

J. Buendía, Diana Guerrero Patiño, D. Sinisterra, 2021, The Turkish journal of pediatrics.

Disability-adjusted life years for respiratory syncytial virus in children under 2 years

F. Polack, J. Buendía, Juana Patricia Sánchez Villamil, 2020, BMC Public Health.

Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage

J. Buendía, D. Sinisterra, José Armando Justinico Castro, 2019, BMC Research Notes.

Effects of Combinational CYP3A5 6986A>G Polymorphism in Graft Liver and Native Intestine on the Pharmacokinetics of Tacrolimus in Liver Transplant Patients: A Meta-Analysis

C. Staatz, J. Buendía, G. Bramuglia, 2014, Therapeutic drug monitoring.

Disability-adjusted Life Years for respiratory syncytial virus in Colombian children.

F. Polack, J. Buendía, Juana Patricia Sánchez Villamil, 2020 .

Budget impact analysis of surfactant therapy for bronchiolitis in critically ill infants: the Colombian National Health System perspective

J. Buendía, Diana Guerrero Patiño, D. Patiño, 2021, BMC Health Services Research.

Cost-Utility of Tiotropium in Patients With Severe Asthma

J. Buendía, Diana Guerrero Patiño, D. Patiño, 2021 .

Cost‐utility of tiotropium for children with severe asthma in patients aged 1–5 years

C. Rodríguez‐Martínez, M. Sossa-Briceño, J. Buendía, 2021, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Inappropriate antibiotic prescribing for acute bronchiolitis in Colombia: a predictive model

J. Buendía, J. E. Feliciano-Alfonso, 2021, Journal of pharmaceutical policy and practice.

RSV and exposure to cigarette smoking as risk factors for severe bronchiolitis in a tropical country

R. Acuña-Cordero, J. Buendía, R. Acuña‐Cordero, 2020 .

Tiotropium for children and adolescents with severe asthma

J. Buendía, Diana Guerrero Patiño, Jefferson Antonio Buendía, 2022, The Journal of asthma : official journal of the Association for the Care of Asthma.

Cost‐effectiveness analysis of phenotypic‐guided versus guidelines‐guided bronchodilator therapy in viral bronchiolitis

Geovanny F. Perez, J. Castro‐Rodriguez, C. Rodríguez‐Martínez, 2020, Pediatric pulmonology.

The role of high carbohydrate-rich food intake and severity of asthma exacerbation in children between 2 to 6 years aged

R. Acuña-Cordero, J. Buendía, Diana Guerrero Patiño, 2022, The Journal of asthma : official journal of the Association for the Care of Asthma.

Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis

J. Buendía, Erika Fernanda Lindarte, D. Guerrero Patiño, 2022, BMC Pulmonary Medicine.

High-flow nasal cannula for acute exacerbation of chronic obstructive pulmonary disease: a Cost-utility analysis

J. Buendía, D. Guerrero Patiño, Jefferson Antonio Buendía, 2022, medRxiv.

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis

J. Buendía, Diana Guerrero Patiño, D. Guerrero Patiño, 2022, BMC Pulmonary Medicine.

Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma

C. Rodríguez‐Martínez, R. Acuña-Cordero, J. Buendía, 2020, Cost Effectiveness and Resource Allocation.

Are the High Smoking Rates Related to COVID-19 Outbreaks?

Andres F Zuluaga, J. Buendía, M. A. Giraldo, 2020 .

Cost-effectiveness of procalcitonin for detection of serious bacterial infections in children presenting with fever without source

J. Buendía, Diana Guerrero Patiño, D. Guerrero Patiño, 2022, BMC Pediatrics.

[Cost-effectiveness of diagnostic strategies of severe bacterial infection in infants with fever without a source].

J. Buendía, J. P. Sánchez-Villamil, Gabriela Urman, 2016, Biomedica : revista del Instituto Nacional de Salud.

Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation

J. Buendía, M. T. García de Dávila, G. Bramuglia, 2020, Pharmaceutics.

Vitamin A supplementation for the prevention of chronic lung disease in premature infants: A cost‐utility analysis

J. Buendía, Erika Fernanda Lindarte, D. G. Patiño, 2022, Pediatric pulmonology.

The use of ipratropium bromide for treating moderate to severe asthma exacerbations in pediatric patients in an emergency setting: A cost‐effectiveness analysis

C. Rodríguez‐Martínez, M. Sossa-Briceño, J. Buendía, 2021, Pediatric pulmonology.

Impact of the updating of clinical guidelines for RSV bronchiolitis on the use of diagnostic testing and medications in tertiary hospitals in Colombia

J. Buendía, D. G. Patiño, D. Patiño, 2022, The Pan African medical journal.

Frequency of CYP 3 A 5 genetic polymorphisms and Tacrolimus 2 pharmacokinetics in Pediatric Liver Transplantation 3

J. Buendía, O. Imventarza, G. Bramuglia, 2019 .

Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis

J. Buendía, D. Guerrero Patiño, 2020, F1000Research.

OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis

J. Buendía, Erika Fernanda Lindarte, D. Patiño, 2022, BMC Pulmonary Medicine.

Survival Time to Biopsy-Proven Acute Rejection and Tacrolimus Adverse Drug Reactions in Pediatric Liver Transplantation

Dan S. Borgnia, M. D. de Dávila, J. Woillard, 2018, Therapeutic drug monitoring.

Chemoprophylaxis in contacts of patients with leprosy: systematic review and meta-analysis.

L. Reveiz, D. Téllez, J. Buendía, 2009, Revista panamericana de salud publica = Pan American journal of public health.

[Flexible Fiberoptic Bronchoscopy in children with persistent atelectasis: a case series report].

J. Buendía, H. Talamoni, N. Pisapia, 2015, Archivos argentinos de pediatria.

Can magnitude and days with fever predict urinary tract infection in infants with fever without source?

Dione Benjumea-Bedoya, J. Buendía, Marisela Bedoya, 2021 .

Occult bacteraemia in children with fever without focus though previously vaccinated against pneumococcus

Dione Benjumea-Bedoya, J. Buendía, Marisela Bedoya, 2022, Tropical doctor.

Cost of Illness of Paraquat Poisoning in Colombia

J. Buendía, G. R. Restrepo Chavarriaga, 2019, Value in Health Regional Issues.

Burden of paraquat poisoning in the department of Antioquia, Colombia

Andres F Zuluaga, J. Buendía, Gabriel Jaime Restrepo Chavarriaga, 2019, BMC Pharmacology and Toxicology.

[Physicians´ insight about adverse drug reaction to frequently used medication groups in Bogotá (Colombia)].

Andres F Zuluaga, J. Buendía, 2014, Biomedica : revista del Instituto Nacional de Salud.

Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant Patients.

F. Villamil, M. D. de Dávila, A. Lazarowski, 2015, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

Social and economic variables related with Paraquat self-poisoning: an ecological study

Andres F Zuluaga, J. Buendía, G. R. Restrepo Chavarriaga, 2019, BMC Public Health.

Implications of global pricing policies on access to innovative drugs: the case of trastuzumab in seven Latin American countries Short title: Global pricing and access: trastuzumab in Latin America

M. Drummond, F. Augustovski, O. U. Garay, 2018 .

Dupilumab in children with moderate‐to‐severe asthma: A cost utility analysis

J. Buendía, D. Patiño, 2022, Pediatric pulmonology.

A predictive model of inappropriate use of medical tests and medications in Bronchiolitis

J. Buendía, C. Rodriguez, 2020, The Pan African medical journal.

Costs of Respiratory Syncytial Virus Hospitalizations in Colombia

J. Buendía, D. Patiño, 2020, PharmacoEconomics - Open.

Clinical Manifestations and Outcomes of Respiratory Syncytial Virus Infection in Children Less Than Two Years in Colombia

F. Polack, J. Buendía, D. Patiño, 2020, Indian Pediatrics.

The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis

J. Buendía, R. Acuña‐Cordero, 2020, BMC Health Services Research.

Mioclonías inducidas por salbutamol

Andres F Zuluaga, J. Buendía, M. A. Montoya-Giraldo, 2018, Biomédica.

Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia

J. Buendía, D. Patiño, Melisa Lopez Moreno, 2021, Expert review of pharmacoeconomics & outcomes research.

An economic evaluation of trastuzumab as adjuvant treatment of early HER2-positive breast cancer patients in Colombia.

A. Pichón-Riviere, J. Buendía, C. Vallejos, 2013, Biomedica : revista del Instituto Nacional de Salud.

Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children

J. Buendía, D. Patiño, 2023, Cost Effectiveness and Resource Allocation.

Ambrisentan for in pediatric pulmonary arterial hypertension: A cost‐utility analysis

J. Buendía, Erika Fernanda Lindarte, D. Patiño, 2023, Pediatric pulmonology.

Budget Impact Analysis of Hypertonic Saline Inhalations for Infant Bronchiolitis: The Colombian National Health System Perspective.

J. Buendía, D. Patiño, 2021, Value in health regional issues.

Budget impact analysis of high-flow nasal cannula for infant bronchiolitis: the Colombian National Health System perspective

C. Rodríguez‐Martínez, J. Buendía, R. Acuña‐Cordero, 2021, Current medical research and opinion.

Costs of Surfactant Therapy for Bronchiolitis in Critically Ill Infants

J. Buendía, D. Patiño, 2021 .

Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis.

J. Buendía, Erika Fernanda Lindarte, D. Guerrero Patiño, 2023, Value in health regional issues.

Corticosteroids for the treatment of respiratory infection by Mycoplasma pneumoniae in children: A cost‐utility analysis

J. Buendía, D. Patiño, 2023, Pediatric pulmonology.

Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension.

J. Buendía, Erika Fernanda Lindarte, D. Patiño, 2023, Expert review of pharmacoeconomics & outcomes research.

Cost-Utility of Continuous Positive Airway Pressure for Respiratory Distress in Preterm Infants in a Middle-Income Country.

J. Buendía, Ricardo Hernández-Sarmiento, Jorge Enrique Rojas Medina, 2023, Value in Health Regional Issues.

Systematic review and cost‐utility of high flow nasal cannula versus continuous positive airway pressure in children with acute severe or moderate bronchiolitis in Colombia

I. Flórez, J. Buendía, J. E. Feliciano-Alfonso, 2022, Pediatric Pulmonology.

The cost-utility of early use of high-flow nasal cannula in bronchiolitis

C. Rodríguez‐Martínez, J. Buendía, R. Acuña‐Cordero, 2020, Health Economics Review.

The cost‐utility of intravenous magnesium sulfate for treating asthma exacerbations in children

C. Rodríguez‐Martínez, J. Buendía, R. Acuña‐Cordero, 2020, Pediatric pulmonology.

[Attitudes, knowledge and beliefs of patient about anti-hypertensive drugs].

J. Buendía, 2012, Biomedica : revista del Instituto Nacional de Salud.

SMART therapy in adolescent and adults patients with moderate persistent asthma: a cost-utility analysis

J. Buendía, Diana Guerrero Patiño, Jefferson Antonio Buendía, 2021, The Journal of asthma : official journal of the Association for the Care of Asthma.

Cost-utility of use of sputum eosinophil counts to guide management in children with asthma

J. Buendía, H. Talamoni, 2020, The Journal of asthma : official journal of the Association for the Care of Asthma.

As-needed use of short-acting β2-agonists alone versus as-needed use of short-acting β2-agonists plus inhaled corticosteroids in pediatric patients with mild intermittent (step-1) asthma: a cost-effectiveness analysis.

C. Rodríguez‐Martínez, M. Sossa-Briceño, J. Buendía, 2022, Journal of Allergy and Clinical Immunology: In Practice.

Systematic review and meta-analysis of efficacy and safety of continuous positive airways pressure versus high flow oxygen cannula in acute bronchiolitis

J. Buendía, J. E. Feliciano-Alfonso, M. Laverde, 2022, BMC Pediatrics.

[Cost-effectiveness of diagnostic strategies of severe bacterial infection in infants with fever without a source].

J. Buendía, Gabriela Urman, Juana P. Sánchez-Villamil, 2016, Biomedica : revista del Instituto Nacional de Salud.

IMPLICATIONS OF GLOBAL PRICING POLICIES ON ACCESS TO INNOVATIVE DRUGS: THE CASE OF TRASTUZUMAB IN SEVEN LATIN AMERICAN COUNTRIES

M. Drummond, F. Augustovski, O. U. Garay, 2015, International Journal of Technology Assessment in Health Care.

Exploratory analysis of the economically justifiable price of nirsevimab for healthy late‐preterm and term infants in Colombia

C. Rodríguez‐Martínez, J. Buendía, R. Acuña‐Cordero, 2024, Pediatric pulmonology.

Genotype-driven asthma prescribing of inhaled corticosteroids and long-acting β2-agonist: A cost-effectiveness analysis.

J. Buendía, Andrés Felipe Zuluaga Salazar, 2024, Pediatric pulmonology.

Economic evidence supports the cost savings of sputum eosinophil counts to guide the treatment of pediatrics patients with persistent asthma: implications for clinical practice guidelines in middle-income countries

J. Buendía, D. Patiño, Andrés Felipe ZuluagaSalazar, 2023, The Journal of asthma : official journal of the Association for the Care of Asthma.